Sign Up to like & get
recommendations!
1
Published in 2022 at "British Journal of Haematology"
DOI: 10.1111/bjh.18432
Abstract: Patients with multiple myeloma are at increased risk of vascular thromboembolic events (VTEs). This post hoc analysis evaluated VTEs in the randomised phase 2 GRIFFIN study (ClinicalTrials.gov Identifier: NCT02874742) that investigated lenalidomide/bortezomib/dexamethasone (RVd) ± daratumumab (D). Patients…
read more here.
Keywords:
griffin study;
rvd;
lenalidomide bortezomib;
rvd rvd ... See more keywords